Honokiol is a small molecule inhibitor that binds to the transactivation domain of FOXM1 and inhibits FOXM transcriptional activity by preventing its binding to DNA, leading to the suppression of cell proliferation of breast, lung, pancreatic, and prostate cancers. The gene discussed is FOXM1; the disease is prostate cancer.